Stocks to watch: Piramal Pharma aims to double its revenue to $2 billion by FY30, while tripling its Ebitda, said company Chairperson Nandini Piramal.
| Subscribe To Our Free Newsletter |
The Most Valuable Commodity Is Information!
Stocks to watch: Piramal Pharma aims to double its revenue to $2 billion by FY30, while tripling its Ebitda, said company Chairperson Nandini Piramal.
| Subscribe To Our Free Newsletter |
